The Effects of Omega-3 Fatty Acids on Aspirin Resistance.
Phase of Trial: Phase I/II
Latest Information Update: 24 Oct 2012
At a glance
- Drugs Aspirin; Omega-3-acid ethyl esters
- Indications Cardiovascular disorders; Embolism and thrombosis
- Focus Pharmacodynamics
- 28 Jun 2012 Actual patient numbers amended from 26 to 27 as reported by ClinicalTrials.gov.
- 28 Jun 2012 Primary endpoint changed from platelet aggregation to time to clot formation as reported by ClinicalTrials.gov.
- 24 Feb 2010 Actual end date (Jan 2009) and actual number of patients (26) added as reported by ClinicalTrials.gov.